Publications

• Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?
  Barbosa, P. V., Thomas, I.-C., Srinivas, S., Buyyounouski, M. K., Chung, B. I., & Leppert, J. T. (2016). Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?. EUROPEAN UROLOGY, 70(2), 227-230.
• The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial
  Jamshidi, N., Jonasch, E., Zapala, M., Korn, R. L., Brooks, J. D., & Kuo, M. D. (2016). The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial. EUROPEAN RADIOLOGY, 26(8), 2798-2807.
• GSTP1 Loss Results in Accumulation of Oxidative DNA Base Damage and Promotes Prostate Cancer Cell Survival Following Exposure to Protracted Oxidative Stress
  Mian, O. Y., Khattab, M. H., Hedayati, M., Coulter, J., Abubaker-Sharif, B., & DeWeese, T. L. (2016). GSTP1 Loss Results in Accumulation of Oxidative DNA Base Damage and Promotes Prostate Cancer Cell Survival Following Exposure to Protracted Oxidative Stress. PROSTATE, 76(2), 199-206.
• Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort Newcomb, L. F., Thompson, I. M., Boyer, H. D., Brooks, J. D., Carroll, P. R., & Lin, D. W. (2016). Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. JOURNAL OF UROLOGY, 195(2), 313-320.
  
• Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Lotan, T. L., Wei, W., Ludkovski, O., Morais, C. L., Guedes, L. B., & Squire, J. A. (2016). Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
  
• Reply to being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff point. Gomez, S. L., Martínez, M. E., Brooks, J. D., Cheng, I., Lichtensztajn, D., & Murphy, J. D. (2016). Reply to being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff point. Cancer.
  
• Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Tretiakova, M. S., Wei, W., Boyer, H. D., Newcomb, L. F., Hawley, S., & Brooks, J. D. (2016). Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate cancer and prostatic diseases.
  
• Loss of expression of AZGP1 is associated with worse clinical outcomes in a multi-institutional radical prostatectomy cohort. Brooks, J. D., Wei, W., Pollack, J. R., West, R. B., Shin, J. H., & Fazli, L. (2016). Loss of expression of AZGP1 is associated with worse clinical outcomes in a multi-institutional radical prostatectomy cohort. The Prostate.
  
• Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator Ankerst, D. P., Xia, J., Thompson, I. M., Hoefler, J., Newcomb, L. F., & Lin, D. W. (2015). Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. EUROPEAN UROLOGY, 68(6), 1083-1088.
  
• The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma Jamshidi, N., Jonasch, E., Zapala, M., Korn, R. L., Aganovic, L., & Kuo, M. D. (2015). The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma. RADIOLOGY, 277(1), 114-123.
  
• A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers Jokerst, J. V., Chen, Z., Xu, L., Nolley, R., Chang, E., & Gambhir, S. S. (2015). A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers. PLOS ONE, 10(9).
  
• A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer Troyer, D. A., Jamaspishvili, T., Wei, W., Feng, Z., Good, J., & Squire, J. A. (2015). A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. PROSTATE, 75(11), 1206-1215.
  
• Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients Brooks, J. D., Wei, W., Hawley, S., Auman, H., Newcomb, L., & McKenney, J. K. (2015). Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. PLOS ONE, 10(7).
  
• The impact of robotic surgery on the surgical management of prostate cancer in the USA Chang, S. L., Kibel, A. S., Brooks, J. D., & Chung, B. I. (2015). The impact of robotic surgery on the surgical management of prostate cancer in the USA. BJU INTERNATIONAL, 115(6), 929-936.
  
• Re: Nationwide prevalence of lymph node metastases in Gleason score 3?+?3?=?6 prostate cancer: authors' reply. Sieh, W., Lichtensztajn, D. Y., Gomez, S. L., Liu, J.-J., Chung, B. I., & Brooks, J. D. (2015). Re: Nationwide prevalence of lymph node metastases in Gleason score 3?+?3?=?6 prostate cancer: authors' reply. Pathology, 47(4), 394-395.
  
• Increased Risk of Cancer in Infertile Men: Analysis of US Claims Data Eisenberg, M. L., Li, S., Brooks, J. D., Cullen, M. R., & Baker, L. C. (2015). Increased Risk of Cancer in Infertile Men: Analysis of US Claims Data. JOURNAL OF UROLOGY, 193(5), 1596-1601.
  
• NUSAP 1 Expression Is Upregulated by Loss of RB1 in Prostate Cancer Cells Gordon, C. A., Gulzar, Z. G., & Brooks, J. D. (2015). NUSAP 1 Expression Is Upregulated by Loss of RB1 in Prostate Cancer Cells. PROSTATE, 75(5), 517-526.
  
• Biologic Differences Between Peripheral and Transition Zone Prostate Cancer Lee, J. J., Thomas, I.-C., Nolley, R., Ferrari, M., Brooks, J. D., & Leppert, J. T. (2015). Biologic Differences Between Peripheral and Transition Zone Prostate Cancer. PROSTATE, 75(2), 183-190.
  
• Novel Fusion Transcripts Associate with Progressive Prostate Cancer Yu, Y. P., Ding, Y., Chen, Zh., Liu, S., Michalopoulos, A., & Luo, J.-H. (2014). Novel Fusion Transcripts Associate with Progressive Prostate Cancer. AMERICAN JOURNAL OF PATHOLOGY, 184(10), 2840-2849.
  
• Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance Busch, J., Magheli, A., Leva, N., Ferrari, M., Kramer, J., & Gonzalgo, M. L. (2014). Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance. BJU INTERNATIONAL, 114(4), 517-521.
  
• The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-C-13]-ketoisocaproate Billingsley, K. L., Park, J. M., Josan, S., Hurd, R., Mayer, D., & Spielman, D. (2014). The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-C-13]-ketoisocaproate. MAGNETIC RESONANCE IMAGING, 32(7), 791-795.
  
• Increased Expression of GCNT1 is Associated With Altered O-glycosylation of PSA, PAP, and MUC1 in Human Prostate Cancers Chen, Z., Gulzar, Z. G., St Hill, C. A., Walcheck, B., & Brooks, J. D. (2014). Increased Expression of GCNT1 is Associated With Altered O-glycosylation of PSA, PAP, and MUC1 in Human Prostate Cancers. PROSTATE, 74(10), 1059-1067.
  
• Nationwide prevalence of lymph node metastases in Gleason score 3+3=6 prostate cancer Liu, J.-J., Lichtensztajn, D. Y., Gomez, S. L., Sieh, W., Chung, B. I., & Brooks, J. D. (2014). Nationwide prevalence of lymph node metastases in Gleason score 3+3=6 prostate cancer. PATHOLOGY, 46(4), 306-310.
  
• Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., & Leppert, J. T. (2014). Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. International journal of cancer. Journal international du cancer, 134(9), 2245-2252.
  
• Prostate Cancer Risk Profiles of Asian-American Men: Disentangling the Effects of Immigration Status and Race/Ethnicity Lichtensztajn, D. Y., Gomez, S. L., Sieh, W., Chung, B. I., Cheng, I., & Brooks, J. D. (2014). Prostate Cancer Risk Profiles of Asian-American Men: Disentangling the Effects of Immigration Status and Race/Ethnicity. JOURNAL OF UROLOGY, 191(4), 952-956.
  
• Reply. Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Brooks, J. D., & Saigal, C. S. (2014). Reply. Urology, 83(4), 779-780.
  
• Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Srinivas, S., & Saigal, C. S. (2014). Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma. UROLOGY, 83(4), 774-779.
  
• DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. Lasseigne, B. N., Burwell, T. C., Patil, M. A., Absher, D. M., Brooks, J. D., & Myers, R. M. (2014). DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC medicine, 12(1), 235.
  
• Identification and Characterization of 2 Testicular Germ Cell Markers, Glut3 and CyclinA2 Howitt, B. E., Brooks, J. D., Jones, S., & Higgins, J. Pt. (2013). Identification and Characterization of 2 Testicular Germ Cell Markers, Glut3 and CyclinA2. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 21(5), 401-407.
  
• Smoking and adverse outcomes at radical prostatectomy Ngo, T. C., Lee, J. J., Brooks, J. D., Nolley, R., Ferrari, M., & Presti, J. C. (2013). Smoking and adverse outcomes at radical prostatectomy. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 31(6), 749-754.
  
• Evaluation of SF-1 Expression in Testicular Germ Cell Tumors: A Tissue Microarray Study of 127 Cases Sangoi, A. R., McKenney, J. K., Brooks, J. D., & Higgins, J. P. (2013). Evaluation of SF-1 Expression in Testicular Germ Cell Tumors: A Tissue Microarray Study of 127 Cases. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 21(4), 318-321.
  
• Epigenetic changes in histologically normal prostate tissues. Brooks, J. D. (2013). Epigenetic changes in histologically normal prostate tissues. journal of urology, 189(6), 2020-2021.
  
• Comprehensive gene expression changes associated with mouse postnatal kidney development. Wu, B., Sahoo, D., & Brooks, J. D. (2013). Comprehensive gene expression changes associated with mouse postnatal kidney development. journal of urology, 189(6), 2385-2390.
  
• Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study Lin, D. W., Newcomb, L. F., Brown, E. C., Brooks, J. D., Carroll, P. R., & Nelson, P. S. (2013). Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study. CLINICAL CANCER RESEARCH, 19(9), 2442-2450.
  
• Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1 Gulzar, Z. G., McKenney, J. K., & Brooks, J. D. (2013). Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. ONCOGENE, 32(1), 70-77.
  
• Managing localized prostate cancer in the era of prostate-specific antigen screening. Brooks, J. D. (2013). Managing localized prostate cancer in the era of prostate-specific antigen screening. Cancer.
  
• Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape Day, K., Waite, L. L., Thalacker-Mercer, A., West, A., Bamman, M. M., & Absher, D. (2013). Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape. GENOME BIOLOGY, 14(9).
  
• Treatment and mortality in men with localized prostate cancer: a population-based study in California. Sieh W, Lichtensztajn DY, Nelson DO, Brooks JD, & Chang ET. (2013). Treatment and mortality in men with localized prostate cancer: a population-based study in California. The Open Prostate Cancer Journal, 6.
  
• A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers: The Canary Prostate Cancer Tissue Microarray Hawley, S., Fazli, L., McKenney, J. K., Simko, J., Troyer, D., & Brooks, J. D. (2013). A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers: The Canary Prostate Cancer Tissue Microarray. ADVANCES IN ANATOMIC PATHOLOGY, 20(1), 39-44.
  
• mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer Cann, G. M., Gulzar, Z. G., Cooper, S., Li, R., Luo, S., & Talasaz, Aa. H. (2012). mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer. PLOS ONE, 7(11).
  
• Evaluation of Putative Renal Cell Carcinoma Markers PAX-2, PAX-8, and hKIM-1 in Germ Cell Tumors: A Tissue Microarray Study of 100 Cases Sangoi, A. R., McKenney, J. K., Brooks, J. D., Bonventre, J. V., & Higgins, J. P. (2012). Evaluation of Putative Renal Cell Carcinoma Markers PAX-2, PAX-8, and hKIM-1 in Germ Cell Tumors: A Tissue Microarray Study of 100 Cases. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(5), 451-453.
  
• Gene Expression Changes Induced by Unilateral Ureteral Obstruction in Mice Wu, B., & Brooks, J. D. (2012). Gene Expression Changes Induced by Unilateral Ureteral Obstruction in Mice. JOURNAL OF UROLOGY, 188(3), 1033-1041.
  
• Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness Huang, S., Gulzar, Z. G., Salari, K., Lapointe, J., Brooks, J. D., & Pollack, J. R. (2012). Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. ONCOGENE, 31(37), 4164-4170.
  
• Methods for registration of magnetic resonance images of ex vivo prostate specimens with histology Kimm, S. Y., Tarin, T. V., Lee, J. H., Hu, B., Jensen, K., & Brooks, J. D. (2012). Methods for registration of magnetic resonance images of ex vivo prostate specimens with histology. JOURNAL OF MAGNETIC RESONANCE IMAGING, 36(1), 206-212.
  
• Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence Truong, M., Yang, B., Wagner, J., Kobayashi, Y., Rajamanickam, V., & Jarrard, D. F. (2012). Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. BRITISH JOURNAL OF CANCER, 107(1), 100-107.
  
• Performance Characteristics of Prostate-specific Antigen in Patients Undergoing Radical Prostatectomy Liu, J.-J., Ferrari, M., Nolley, R., Brooks, J. D., & Presti, J. C. (2012). Performance Characteristics of Prostate-specific Antigen in Patients Undergoing Radical Prostatectomy. UROLOGY, 79(6), 1336-1339.
  
• Deficiency in Mammalian Histone H2B Ubiquitin Ligase Bre1 (Rnf20/Rnf40) Leads to Replication Stress and Chromosomal Instability Chernikova, S. B., Razorenova, O. V., Higgins, J. P., Sishc, B. J., Nicolau, M., & Brown, J. M. (2012). Deficiency in Mammalian Histone H2B Ubiquitin Ligase Bre1 (Rnf20/Rnf40) Leads to Replication Stress and Chromosomal Instability. CANCER RESEARCH, 72(8), 2111-2119.
  
• LONG-TERM OUTCOMES FROM A PROSPECTIVE TRIAL OF STEREOTACTIC BODY RADIOTHERAPY FOR LOW-RISK PROSTATE CANCER King, C. R., Brooks, J. D., Gill, H., & Presti, J. C. (2012). LONG-TERM OUTCOMES FROM A PROSPECTIVE TRIAL OF STEREOTACTIC BODY RADIOTHERAPY FOR LOW-RISK PROSTATE CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(2), 877-882.
  
• Translational genomics: The challenge of developing cancer biomarkers Brooks, J. D. (2012). Translational genomics: The challenge of developing cancer biomarkers. GENOME RESEARCH, 22(2), 183-187.
  
• PIVOT and the challenges of localized prostate cancer care Weinberg, A. E., & Brooks, J. D. (2012). PIVOT and the challenges of localized prostate cancer care. Translational Andrology and Urology.
  
• The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study McKenney, J. K., Simko, J., Bonham, M., True, L. D., Troyer, D., & Brooks, J. D. (2011). The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study. JOURNAL OF UROLOGY, 186(2), 465-469.
  
• DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer Kobayashi, Y., Absher, D. M., Gulzar, Z. G., Young, S. R., McKenney, J. K., & Sherlock, G. (2011). DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. GENOME RESEARCH, 21(7), 1017-1027.
  
• Integrated genomic analyses of ovarian carcinoma Bell, D., Berchuck, A., Birrer, M., Chien, J., Cramer, D. W., & Thomson, E. (2011). Integrated genomic analyses of ovarian carcinoma. NATURE, 474(7353), 609-615.
  
• Small Prostate Size and High Grade Disease-Biology or Artifact? Liu, J.-J., Brooks, J. D., Ferrari, M., Nolley, R., & Presti, J. C. (2011). Small Prostate Size and High Grade Disease-Biology or Artifact?. JOURNAL OF UROLOGY, 185(6), 2108-2111.
  
• A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer Malhotra, S., Lapointe, J., Salari, K., Higgins, J. P., Ferrari, M., & Pollack, J. R. (2011). A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer. PLOS ONE, 6(5).
  
• Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival Chung, B. I., Tarin, T. V., Ferrari, M., & Brooks, J. D. (2011). Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 29(3), 314-318.
  
• Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy Hsu, M., Chang, S. L., Ferrari, M., Nolley, R., Presti, J. C., & Brooks, J. D. (2011). Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy. INTERNATIONAL JOURNAL OF UROLOGY, 18(4), 272-279.
  
• Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases Sangoi, A. R., Karamchandani, J., Lane, B., Higgins, J. P., Rouse, R. V., & McKenney, J. K. (2011). Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. MODERN PATHOLOGY, 24(3), 425-429.
  
• The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis Quick, C. M., Gokden, N., Sangoi, A. R., Brooks, J. D., & McKenney, J. K. (2010). The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis. HUMAN PATHOLOGY, 41(8), 1145-1149.
  
• Canary Prostate Active Surveillance Study: Design of a Multi-institutional Active Surveillance Cohort and Biorepository Newcomb, L. F., Brooks, J. D., Carroll, P. R., Feng, Z., Gleave, M. E., & Lin, D. W. (2010). Canary Prostate Active Surveillance Study: Design of a Multi-institutional Active Surveillance Cohort and Biorepository. UROLOGY, 75(2), 407-413.
  
• Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Brannon, A. R., Reddy, A., Seiler, M., Arreola, A., Moore, D. T., & Rathmell, W. K. (2010). Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes & cancer, 1(2), 152-163.
  
• Gene expression changes induced by genistein in the prostate cancer cell line LNCaP Bhamre S, Sahoo D, Tibshirani R, Dill DL, & Brooks JD. (2010). Gene expression changes induced by genistein in the prostate cancer cell line LNCaP. The Open Prostate Cancer Journal, 3.
  
• Adjuvant docetaxel and abbreviated androgen deprivation therapy in patients with high risk prostate cancer Bazan JG, King CR, Brooks JD, & Srinivas S. (2010). Adjuvant docetaxel and abbreviated androgen deprivation therapy in patients with high risk prostate cancer. The Open Prostate Cancer Journal, 3.
  
• Prognostic significance of prostate cancer originating from the transition zone King, C. R., Ferrari, M., & Brooks, J. D. (2009). Prognostic significance of prostate cancer originating from the transition zone. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 27(6), 592-597.
  
• Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes Holterhus, P.-M., Bebermeier, J.-H., Werner, R., Demeter, J., Richter-Unruh, A., & Hiort, O. (2009). Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. BMC GENOMICS, 10.
  
• Alteration of Gene Expression Signatures of Cortical Differentiation and Wound Response in Lethal Clear Cell Renal Cell Carcinomas Zhao, H., Ma, Z., Tibshirani, R., Higgins, J. Pt., Ljungberg, B., & Brooks, J. D. (2009). Alteration of Gene Expression Signatures of Cortical Differentiation and Wound Response in Lethal Clear Cell Renal Cell Carcinomas. PLOS ONE, 4(6).
  
• Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome Appari, M., Werner, R., Wuensch, L., Cario, G., Demeter, J., & Holterhus, P.-M. (2009). Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. JOURNAL OF MOLECULAR MEDICINE-JMM, 87(6), 623-632.
  
• Prostatic Soy Isoflavone Concentrations Exceed Serum Levels After Dietary Supplementation Gardner, C. D., Oelrich, B., Liu, J. P., Feldman, D., Franke, A. A., & Brooks, J. D. (2009). Prostatic Soy Isoflavone Concentrations Exceed Serum Levels After Dietary Supplementation. PROSTATE, 69(7), 719-726.
  
• Recommendations for the Reporting of Surgically Resected Specimens of Renal Cell Carcinoma Higgins, J. P., McKenney, J. K., Brooks, J. D., Argani, P., & Epstein, J. I. (2009). Recommendations for the Reporting of Surgically Resected Specimens of Renal Cell Carcinoma. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(5), 623-?.
  
• Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients Swami, S., Krishnan, A. V., Moreno, J., Bhattacharya, R. S., Gardner, C., & Feldman, D. (2009). Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. INTERNATIONAL JOURNAL OF CANCER, 124(9), 2050-2059.
  
• Recommendations for the reporting of surgically resected specimens of renal cell carcinoma The Association of Directors of Anatomic and Surgical Pathology Higgins, J. P., McKenney, J. K., Brooksd, J. D., Argani, P., & Epstein, J. I. (2009). Recommendations for the reporting of surgically resected specimens of renal cell carcinoma The Association of Directors of Anatomic and Surgical Pathology. HUMAN PATHOLOGY, 40(4), 456-463.
  
• STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL King, C. R., Brooks, J. D., Gill, H., Pawlicki, T., Cotrutz, C., & Presti, J. C. (2009). STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 73(4), 1043-1048.
  
• Temporal Changes in Gene Expression Induced by Sulforaphane in Human Prostate Cancer Cells Bhamre, S., Sahoo, D., Tibshirani, R., Dill, D. L., & Brooks, J. D. (2009). Temporal Changes in Gene Expression Induced by Sulforaphane in Human Prostate Cancer Cells. PROSTATE, 69(2), 181-190.
  
• CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. Williams, A. A., Higgins, J. Pt., Zhao, H., Ljunberg, B., & Brooks, J. D. (2009). CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. BMC clinical pathology, 9, 9-?.
  
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways Chin, L., Meyerson, M., Aldape, K., Bigner, D., Mikkelsen, T., & Thomson, E. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. NATURE, 455(7216), 1061-1068.
  
• Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle Thompson, M., Lapointe, J., Choi, Y.-L., Ong, D. E., Higgins, J. P., & Pollack, J. R. (2008). Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. PROSTATE, 68(11), 1248-1256.
  
• Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy King, C. R., Presti, J. C., Brooks, J. D., Gill, H., & Spiotto, M. T. (2008). Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 70(5), 1472-1477.
  
• hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature Lapointe, J., Malhotra, S., Higgins, J. P., Bair, E., Thompson, M., & Pollack, J. R. (2008). hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 32(2), 205-209.
  
• The impact of tumor volume on outcomes after radical prostatectomy: Implications for prostate cancer screening. James D. Brooks, Robert Tibshirani, Michelle Ferrari, Joseph C. Presti, Jr., & Christopher R. King. (2008). The impact of tumor volume on outcomes after radical prostatectomy: Implications for prostate cancer screening. The Open Prostate Cancer Journal, 1.
  
• Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome Holterhus, P.-M., Deppe, U., Werner, R., Richter-Unruh, A., Bebermeier, J.-H., & Brooks, J. D. (2007). Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome. BMC GENOMICS, 8.
  
• Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis Lapointe, J., Li, C., Giacomini, C. P., Salari, K., Huang, S., & Pollack, J. R. (2007). Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. CANCER RESEARCH, 67(18), 8504-8510.
  
• Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Higgins, J. Pt., Kaygusuz, G., Wang, L., Montgomery, K., Mason, V., & Brooks, J. D. (2007). Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 31(5), 673-680.
  
• A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells Li, T.-H., Zhao, H., Peng, Y., Beliakoff, J., Brooks, J. D., & Sun, Z. (2007). A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. NUCLEIC ACIDS RESEARCH, 35(8), 2767-2776.
  
• A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis Lapointe, J., Kim, Y. H., Miller, M. A., Li, C., Kaygusuz, G., & Pollack, J. R. (2007). A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. MODERN PATHOLOGY, 20(4), 467-473.
  
• Endothelin-1 promotes cell survival in renal cell carcinoma through the ETA receptor Pflug, B. R., Zheng, H., Udan, M. S., D'Antonio, J. M., Marshall, F. F., & Nelson, J. B. (2007). Endothelin-1 promotes cell survival in renal cell carcinoma through the ETA receptor. CANCER LETTERS, 246(1-2), 139-148.
  
• Selenomethionine induced transcriptional programs in human prostate cancer cells Zhao, H., & Brooks, J. D. (2007). Selenomethionine induced transcriptional programs in human prostate cancer cells. JOURNAL OF UROLOGY, 177(2), 743-750.
  
• Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues Zhao, H., Ramos, C. F., Brooks, J. D., & Peehl, D. M. (2007). Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. JOURNAL OF CELLULAR PHYSIOLOGY, 210(1), 111-121.
  
• Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription Bebermeier, J.-H., Brooks, J. D., DePrimo, S. E., Werner, R., Deppe, U., & Holterhus, P.-M. (2006). Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. JOURNAL OF MOLECULAR MEDICINE-JMM, 84(11), 919-931.
  
• Application of genomic technologies to human prostate cancer Li, S., Bhamre, S., Lapointe, J., Pollack, J. R., & Brooks, J. D. (2006). Application of genomic technologies to human prostate cancer. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 10(3), 261-275.
  
• Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade King, C. R., McNeal, J. E., Gill, H., Brooks, J. D., Srinivas, S., & Presti, J. C. (2006). Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade. UROLOGY, 67(6), 1229-1234.
  
• Refractory hematuria from amyloidosis successfully treated by splenectomy Ma, J. F., Coutre, S. E., Curet, M. J., & Brooks, J. D. (2006). Refractory hematuria from amyloidosis successfully treated by splenectomy. UROLOGY, 67(5).
  
• Modest induction of phase 2 enzyme activity in the F-344 rat prostate Jones, S. B., & Brooks, J. D. (2006). Modest induction of phase 2 enzyme activity in the F-344 rat prostate. BMC CANCER.
  
• Gene expression profiling predicts survival in conventional renal cell carcinoma Zhao, H. J., Ljungberg, B., Grankvist, K., Rasmuson, T., Tibshirani, R., & Brooks, J. D. (2006). Gene expression profiling predicts survival in conventional renal cell carcinoma. PLOS MEDICINE, 3(1), 115-124.
  
• The application of genomic and proteomic approaches to human prostate cancer in developing diagnostic and prognostic markers Brooks, J. D. (2006). The application of genomic and proteomic approaches to human prostate cancer in developing diagnostic and prognostic markers. Urologic Oncology , 24.
  
• The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer Kim, H., Lapointe, J., Kaygusuz, G., Ong, D. E., Li, C. D., & Pollack, J. R. (2005). The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. CANCER RESEARCH, 65(18), 8118-8124.
  
• Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy Patel, D. A., Presti, J. C., McNeal, J. E., Gill, H., Brooks, J. D., & King, C. R. (2005). Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. JOURNAL OF CLINICAL ONCOLOGY, 23(25), 6157-6162.
  
• Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines Zhao, H. J., Kim, Y., Wang, P., Lapointe, J., Tibshirani, R., & Brooks, J. D. (2005). Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. PROSTATE, 63(2), 187-197.
  
• Juvenile posttraumatic high-flow priapism: current management dilemmas Marotte, J. B., Brooks, J. D., Sze, D., & Kennedy, W. A. (2005). Juvenile posttraumatic high-flow priapism: current management dilemmas. JOURNAL OF PEDIATRIC SURGERY, 40(4).
  
• Reg IV: A promising marker of hormone refractory metastatic prostate cancer Gu, Z. N., Rubin, M. A., Yang, Y., DePrimo, S. E., Zhao, H. J., & Reiter, R. E. (2005). Reg IV: A promising marker of hormone refractory metastatic prostate cancer. CLINICAL CANCER RESEARCH, 11(6), 2237-2243.
  
• Resveratrol-induced gene expression profiles in human prostate cancer cells Jones, S. B., DePrimo, S. E., Whitfield, M. L., & Brooks, J. D. (2005). Resveratrol-induced gene expression profiles in human prostate cancer cells. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 14(3), 596-604.
  
• Molecular targets of Doxazosin in human prostatic stromal cells Zhao, H. J., Lai, F., Nonn, L., Brooks, J. D., & Peehl, D. M. (2005). Molecular targets of Doxazosin in human prostatic stromal cells. PROSTATE, 62(4), 400-410.
  
• Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy Lee, K. L., Marotte, J. B., Ferrari, M. K., McNeal, J. E., Brooks, J. D., & Presti, J. C. (2005). Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. UROLOGY, 65(2), 311-315.
  
• Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. Zhang, H., Dong, Y., Zhao, H., Brooks, J. D., Hawthorn, L., & Ip, C. (2005). Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. Cancer genomics & proteomics, 2(2), 97-114.
  
• A transcriptional profile of aging in the human kidney Rodwell, G. Ej., Sonu, R., Zahn, J. M., Lund, J., Wilhelmy, J., & Kim, S. K. (2004). A transcriptional profile of aging in the human kidney. PLOS BIOLOGY, 2(12), 2191-2201.
  
• Vascular invasion predicts recurrence after radical prostatectomy: Stratification of risk based on pathologic variables Ferrari, M. K., McNeal, J. E., Malhotra, S. M., & Brooks, J. D. (2004). Vascular invasion predicts recurrence after radical prostatectomy: Stratification of risk based on pathologic variables. UROLOGY, 64(4), 749-753.
  
• Molecular activity of 1,25-dihydroxyvitamin D-3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis Peehl, D. M., Shinghal, R., Nonn, L., Seto, E., Krishnan, A. V., & Feldman, D. (2004). Molecular activity of 1,25-dihydroxyvitamin D-3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 92(3), 131-141.
  
• Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes? King, C. R., Presti, J. C., Gill, H., Brooks, J., & Hancock, S. L. (2004). Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 59(2), 341-347.
  
• Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population Presti, J. C., Lee, U., Brooks, J. D., & Terris, M. K. (2004). Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population. JOURNAL OF UROLOGY, 171(6), 2199-2202.
  
• Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays Krishnan, A. V., Shinghal, R., Raghavachari, N., Brooks, J. D., Peehl, D. M., & Feldman, D. (2004). Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. PROSTATE, 59(3), 243-251.
  
• Time trends in pathologic features of radical prostatectomy - impact of family history Marotte, J. B., Ferrari, M. K., McNeal, J. E., Brooks, J. D., & Presti, J. C. (2004). Time trends in pathologic features of radical prostatectomy - impact of family history. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 22(3), 169-173.
  
• Biochemical remission after resection of prostate cancer lung metastasis Chao, D. H., Higgins, J. Pt., & Brooks, J. D. (2004). Biochemical remission after resection of prostate cancer lung metastasis. UROLOGY, 63(3).
  
• Gene expression in the normal adult human kidney assessed by complementary DNA microarray Higgins, J. Pt., Wang, L. L., Kambham, N., Montgomery, K., Mason, V., & van de Rijn, M. (2004). Gene expression in the normal adult human kidney assessed by complementary DNA microarray. MOLECULAR BIOLOGY OF THE CELL, 15(2), 649-656.
  
• Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells Zhao, H. J., Whitfield, M. L., Xu, T., Botstein, D., & Brooks, J. D. (2004). Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. MOLECULAR BIOLOGY OF THE CELL, 15(2), 506-519.
  
• Gene expression profiling identifies clinically relevant subtypes of prostate cancer Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., & Pollack, J. R. (2004). Gene expression profiling identifies clinically relevant subtypes of prostate cancer. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(3), 811-816.
  
• Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors Sperger, J. M., Chen, X., Draper, J. S., Antosiewicz, J. E., Chon, C. H., & Thomson, J. A. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 100(23), 13350-13355.
  
• Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray Higgins, J. Pt., Shinghal, R., Gill, H., Reese, J. H., Terris, M., & Brooks, J. D. (2003). Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. AMERICAN JOURNAL OF PATHOLOGY, 162(3), 925-932.
  
• Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy Shinghal, R., Yemoto, C., McNeal, J. E., & Brooks, J. D. (2003). Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy. UROLOGY, 61(2), 380-385.
  
• Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor Holterhus, P. M., Hiort, O., Demeter, J., Brown, P. O., & Brooks, J. D. (2003). Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. GENOME BIOLOGY.
  
• Expression of FKBP12 in benign and malignant vascular endothelium - An immunohistochemical study on conventional sections and tissue microarrays Higgins, J. Pt., Montgomery, K., Wang, L. L., Domanay, E., Warnke, R. A., & van de Rijn, M. (2003). Expression of FKBP12 in benign and malignant vascular endothelium - An immunohistochemical study on conventional sections and tissue microarrays. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 27(1), 58-64.
  
• Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro Brooks, J. D., Goldberg, M. F., Nelson, L. A., Wu, D., & Nelson, W. G. (2002). Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 11(9), 868-875.
  
• Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis Shibata, A., Garcia, M. I., Cheng, I., Stamey, T. A., McNeal, J. E., & Peehl, D. M. (2002). Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis. PROSTATE, 52(4), 269-278.
  
• Microarray analysis in prostate cancer research. Brooks, J. D. (2002). Microarray analysis in prostate cancer research. Current opinion in urology, 12(5), 395-399.
  
• Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells Vidanes, G. M., Paton, V., Wallen, E., Peehl, D. M., Navone, N., & Brooks, J. D. (2002). Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells. PROSTATE, 51(4), 225-230.
  
• Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells Schwarze, S. R., DePrimo, S. E., Grabert, L. M., Fu, V. X., Brooks, J. D., & Jarrard, D. F. (2002). Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(17), 14877-14883.
  
• Anatomy of the rectourethralis muscle Brooks, J. D., Eggener, S. E., & Chao, W. M. (2002). Anatomy of the rectourethralis muscle. EUROPEAN UROLOGY, 41(1), 94-100.
  
• Transcriptional programs activated by exposure of human prostate cancer cells to androgen DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J., & Brooks, J. D. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. GENOME BIOLOGY, 3(7).
  
• Plasma selenium level before diagnosis and the risk of prostate cancer development Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., & Carter, H. B. (2001). Plasma selenium level before diagnosis and the risk of prostate cancer development. JOURNAL OF UROLOGY, 166(6), 2034-2038.
  
• GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells Lin, X. H., Tascilar, M., Lee, W. H., Vles, W. J., Lee, B. H., & Nelson, W. G. (2001). GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. AMERICAN JOURNAL OF PATHOLOGY, 159(5), 1815-1826.
  
• Potent induction of phase 2 enzymes in human prostate cells by sulforaphane Brooks, J. D., Paton, V. G., & Vidanes, G. (2001). Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 10(9), 949-954.
  
• Prevention of prostate cancer DePrimo, S. E., Shinghal, R., Vidanes, G., & Brooks, J. D. (2001). Prevention of prostate cancer. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 15(3), 445-?.
  
• New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents Williams, E. D., & Brooks, J. D. (2001). New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents. UROLOGY, 57(4A), 100-102.
  
• Role of cytologic criteria in the histologic diagnosis of gleason grade 1 prostatic adenocarcinoma McNeal, J. E., Cohen, R. J., & Brooks, J. D. (2001). Role of cytologic criteria in the histologic diagnosis of gleason grade 1 prostatic adenocarcinoma. HUMAN PATHOLOGY, 32(4), 441-446.
  
• Preneoplastic prostate lesions - An opportunity for prostate cancer prevention Nelson, W. G., De Marzo, A. M., DeWeese, T. L., Lin, X. H., Brooks, J. D., & Kensler, T. W. (2001). Preneoplastic prostate lesions - An opportunity for prostate cancer prevention. CANCER PREVENTION, 952, 135-144.
  
• GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas Tchou, J. C., Lin, X. H., Freije, D., Isaacs, W. B., Brooks, J. D., & Nelson, W. G. (2000). GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. INTERNATIONAL JOURNAL OF ONCOLOGY, 16(4), 663-676.
  
• Absence of HinfI restriction abnormalities in renal oncocytoma mitochondrial DNA Brooks, J. D., Marshall, F. F., Isaacs, W. B., & Johns, D. R. (1999). Absence of HinfI restriction abnormalities in renal oncocytoma mitochondrial DNA. MOLECULAR UROLOGY, 3(1), 1-3.
  
• Partial nephrectomy and caval thrombectomy for renal cell carcinoma in a solitary kidney with an accessory renal vein Pruthi, R. S., Angell, S. K., Brooks, J. D., & Gill, H. (1999). Partial nephrectomy and caval thrombectomy for renal cell carcinoma in a solitary kidney with an accessory renal vein. BJU INTERNATIONAL, 83(1), 142-143.
  
• Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent. Brooks, J. D., & Paton, V. (1999). Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent. Prostate cancer and prostatic diseases, 2(S3), S8.
  
• CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia Brooks, J. D., WEINSTEIN, M., Lin, X. H., Sun, Y. H., Pin, S. S., & Nelson, W. G. (1998). CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 7(6), 531-536.
  
• Male pelvic anatomy reconstructed from the visible human data set Brooks, J. D., Chao, W. M., & Kerr, J. (1998). Male pelvic anatomy reconstructed from the visible human data set. JOURNAL OF UROLOGY, 159(3), 868-872.
  
• Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder JACOBS, L. B., Brooks, J. D., & Epstein, J. I. (1997). Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder. HUMAN PATHOLOGY, 28(10), 1152-1157.
  
• The Swedish prostate cancer paradox Walsh, P. C., & Brooks, J. D. (1997). The Swedish prostate cancer paradox. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 277(6), 497-498.
  
• Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer Nelson, J. B., Lee, W. H., Nguyen, S. H., Jarrard, D. F., Brooks, J. D., & Bova, G. S. (1997). Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. CANCER RESEARCH, 57(1), 35-37.
  
• An uncertain role for p53 gene alterations in human prostate cancers Brooks, J. D., Bova, G. S., Ewing, C. M., PIANTADOSI, S., Carter, B. S., & Isaacs, W. B. (1996). An uncertain role for p53 gene alterations in human prostate cancers. CANCER RESEARCH, 56(16), 3814-3822.
  
• Epidemiologic and molecular features of prostate carcinogenesis as clues for new prostate cancer prevention strategies Brooks JD, Lee WH, & Nelson WG. (1996). Epidemiologic and molecular features of prostate carcinogenesis as clues for new prostate cancer prevention strategies. Canadian Journal of Urology, 3(Supplement).
  
• Molecular staging of prostate cancer Lee WH, Brooks JD, & Nelson WG. (1996). Molecular staging of prostate cancer. Canadian Journal of Urology, 3(Supplement).
  
• UPJ obstruction: assessing minimally invasive therapies. Moore, R. G., & Brooks, J. D. (1995). UPJ obstruction: assessing minimally invasive therapies. Contemporary urology, 7(12), 47-?.
  
• COMPARISON OF OPEN AND ENDOUROLOGICAL APPROACHES TO THE OBSTRUCTED URETEROPELVIC JUNCTION Brooks, J. D., Kavoussi, L. R., Preminger, G. M., Schuessler, W. W., & Moore, R. G. (1995). COMPARISON OF OPEN AND ENDOUROLOGICAL APPROACHES TO THE OBSTRUCTED URETEROPELVIC JUNCTION. UROLOGY, 46(6), 791-795.
  
• MOLECULAR-GENETICS AND CHROMOSOMAL ALTERATIONS IN PROSTATE-CANCER Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. Jg., Brooks, J. D., & Ewing, C. M. (1995). MOLECULAR-GENETICS AND CHROMOSOMAL ALTERATIONS IN PROSTATE-CANCER. CANCER, 75(7), 2004-2012.
  
• ALLELIC LOSS OF THE RETINOBLASTOMA GENE IN PRIMARY HUMAN PROSTATIC ADENOCARCINOMAS Brooks, J. D., Bova, G. S., & Isaacs, W. B. (1995). ALLELIC LOSS OF THE RETINOBLASTOMA GENE IN PRIMARY HUMAN PROSTATIC ADENOCARCINOMAS. PROSTATE, 26(1), 35-39.
  
• FREQUENT LOSS OF CHROMOSOME ARMS 8P AND 13Q IN COLLECTING DUCT CARCINOMA (CDC) OF THE KIDNEY Schoenberg, M., Cairns, P., Brooks, J. D., Marshall, F. F., Epstein, J. I., & Sidransky, D. (1995). FREQUENT LOSS OF CHROMOSOME ARMS 8P AND 13Q IN COLLECTING DUCT CARCINOMA (CDC) OF THE KIDNEY. GENES CHROMOSOMES & CANCER, 12(1), 76-80.
  
• MOLECULAR-BIOLOGY OF PROSTATE-CANCER PROGRESSION Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. Jg., Brooks, J. D., & Ewing, C. M. (1995). MOLECULAR-BIOLOGY OF PROSTATE-CANCER PROGRESSION. CANCER SURVEYS, 23, 19-32.
  
• Embryonal adenoma of the kidney: case report Perlman EJ, Brooks J, Gordon AH, Griffin CA, & Schoenberg M. (1995). Embryonal adenoma of the kidney: case report. Journal of Urology, 154.
  
• CYTIDINE METHYLATION OF REGULATORY SEQUENCES NEAR THE PI-CLASS GLUTATHIONE-S-TRANSFERASE GENE ACCOMPANIES HUMAN PROSTATIC CARCINOGENESIS Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., & Nelson, W. G. (1994). CYTIDINE METHYLATION OF REGULATORY SEQUENCES NEAR THE PI-CLASS GLUTATHIONE-S-TRANSFERASE GENE ACCOMPANIES HUMAN PROSTATIC CARCINOGENESIS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 91(24), 11733-11737.
  
• MOLECULAR-BIOLOGY OF PROSTATE-CANCER Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. Jg., Brooks, J. D., & Ewing, C. M. (1994). MOLECULAR-BIOLOGY OF PROSTATE-CANCER. SEMINARS IN ONCOLOGY, 21(5), 514-521.
  
• LAPAROSCOPIC MANAGEMENT OF TESTICULAR PAIN AFTER EMBOLOTHERAPY OF VARICOCELE Brooks, J. D., Moore, R. G., & Kavoussi, L. R. (1994). LAPAROSCOPIC MANAGEMENT OF TESTICULAR PAIN AFTER EMBOLOTHERAPY OF VARICOCELE. JOURNAL OF ENDOUROLOGY, 8(5), 361-363.
  
• Mutations of the VHL tumour suppressor gene in renal carcinoma Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, & Linehan WM. (1994). Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genetics, 7.
  
• GENETIC ALTERATIONS IN PROSTATE-CANCER Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. Jg., Brooks, J. D., & Ewing, C. M. (1994). GENETIC ALTERATIONS IN PROSTATE-CANCER. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 59, 653-659.
  
• TUMOR-SUPPRESSOR GENE ALLELIC LOSS IN HUMAN RENAL CANCERS Brooks, J. D., Bova, G. S., Marshall, F. F., & Isaacs, W. B. (1993). TUMOR-SUPPRESSOR GENE ALLELIC LOSS IN HUMAN RENAL CANCERS. JOURNAL OF UROLOGY, 150(4), 1278-1283.
  
• TUBULARIZED NEOURETHRA FOLLOWING RADICAL RETROPUBIC PROSTATECTOMY Steiner, M. S., Burnett, A. L., Brooks, J. D., Brendler, C. B., STUTZMAN, R. E., & Carter, H. B. (1993). TUBULARIZED NEOURETHRA FOLLOWING RADICAL RETROPUBIC PROSTATECTOMY. JOURNAL OF UROLOGY, 150(2), 407-409.
  
• Regional DNA Hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, & Baylin SB. (1993). Regional DNA Hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Research, 53.
  
• Genetic alterations in prostate cancer - prognostic implications? Isaacs WB, Bova GS, Brooks JD, Ewing CM, Morton RA, & Robinson JC. (1993). Genetic alterations in prostate cancer - prognostic implications?. Akteulle Onkologie, 78.
  
• DOPAMINE UPTAKE BLOCKERS PROTECT AGAINST THE DOPAMINE DEPLETING EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN THE MOUSE STRIATUM Ricaurte, G. A., Langston, J. W., DeLanney, L. E., Irwin, I., & Brooks, J. D. (1985). DOPAMINE UPTAKE BLOCKERS PROTECT AGAINST THE DOPAMINE DEPLETING EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN THE MOUSE STRIATUM. NEUROSCIENCE LETTERS, 59(3), 259-264.